UnitedHealth Group Inc

UNH-N

NYSE:UNH

306.97
1.99 (0.65%)
UnitedHealth Group Inc. is an American for profit managed health care company based in Minnetonka, Minnesota. It is sixth in the United States on the Fortune 500.
More at Wikipedia

Analysis and Opinions about UNH-N

Signal
Opinion
Expert
WATCH
WATCH
December 6, 2018
They are just so consistent. The health care sector is just so influenced by politics. But these guys reduce costs for governments. This stock has been spectacular. They have scale and a phenomenal management team that returns capital to shareholders. He would not buy more at this time.
Show full opinionHide full opinion
They are just so consistent. The health care sector is just so influenced by politics. But these guys reduce costs for governments. This stock has been spectacular. They have scale and a phenomenal management team that returns capital to shareholders. He would not buy more at this time.
BUY
BUY
December 6, 2018
Looks very strong. The technical strength is strong. PEG ratio is 1.4. Likes it. Longer term, 1 year, 24 months this is a good place to be.
Show full opinionHide full opinion
Looks very strong. The technical strength is strong. PEG ratio is 1.4. Likes it. Longer term, 1 year, 24 months this is a good place to be.
TOP PICK
TOP PICK
December 3, 2018
They've had a great run and are the poster child of the U.S. health insurance space. They continue to put up 15% bottom-line growth. (Analysts’ price target is $304.74)
Show full opinionHide full opinion
They've had a great run and are the poster child of the U.S. health insurance space. They continue to put up 15% bottom-line growth. (Analysts’ price target is $304.74)
TOP PICK
TOP PICK
November 12, 2018
Healthcare is a fantastic bull market. They have a great chart, in atrong uptrend since 2014 with higher highs and higher lows. (Analysts’ price target is $300.87)
Show full opinionHide full opinion
Healthcare is a fantastic bull market. They have a great chart, in atrong uptrend since 2014 with higher highs and higher lows. (Analysts’ price target is $300.87)
BUY
BUY
November 9, 2018
They have very good management. Very strong on momentum and most of the technicals. It is one of his top picks. One of his top picks in the sector. Buy on the dip if possible.
Show full opinionHide full opinion
They have very good management. Very strong on momentum and most of the technicals. It is one of his top picks. One of his top picks in the sector. Buy on the dip if possible.
HOLD
HOLD
October 17, 2018

The company came out with very strong earnings – 12% growth y-o-y. Despite the run in share prices currently, he thinks there is still lots of runway. The companies touches on so many aspects of public health in the US and suggests politicians will avoid public cuts in spending going forward. He sees their growth continuing. Yield 1.3%.

Show full opinionHide full opinion

The company came out with very strong earnings – 12% growth y-o-y. Despite the run in share prices currently, he thinks there is still lots of runway. The companies touches on so many aspects of public health in the US and suggests politicians will avoid public cuts in spending going forward. He sees their growth continuing. Yield 1.3%.

BUY
BUY
August 21, 2018

This is a very positive company. This is a large US insurer, with a separate interest in health records and technology. The company has done very well but still trades at a reasonable valuation.

Show full opinionHide full opinion

This is a very positive company. This is a large US insurer, with a separate interest in health records and technology. The company has done very well but still trades at a reasonable valuation.

HOLD
HOLD
August 20, 2018

Its technicals and fundamentals have nicely converged and is now perfectly priced. There's no upside or downside here. No momentum to rise. Maybe in another year there'll be enough earnings.

Show full opinionHide full opinion

Its technicals and fundamentals have nicely converged and is now perfectly priced. There's no upside or downside here. No momentum to rise. Maybe in another year there'll be enough earnings.

TOP PICK
TOP PICK
August 13, 2018

Healthcare is in a secular bull market. Fantastsic trend upwards over the past year. Executing well. (Analysts' price target: $280.23)

Show full opinionHide full opinion

Healthcare is in a secular bull market. Fantastsic trend upwards over the past year. Executing well. (Analysts' price target: $280.23)

PAST TOP PICK
PAST TOP PICK
July 5, 2018

(A Top Pick September 14/17 - Up 27%.) A tremendous growth story. Still a holding. Dominant leaders in the space.

Show full opinionHide full opinion

(A Top Pick September 14/17 - Up 27%.) A tremendous growth story. Still a holding. Dominant leaders in the space.

PAST TOP PICK
PAST TOP PICK
May 9, 2018

(A Top Pick June 13/17 Up 29%) He sees no reason to move away from this holding. It is a consistent performer and will continue to do well. The independant gorilla in the Medicare and Medicaid space in the US. Did have a little bit of a pullback and consolidation. A very positive story and good momentum based on last quarter earnings.

Show full opinionHide full opinion

(A Top Pick June 13/17 Up 29%) He sees no reason to move away from this holding. It is a consistent performer and will continue to do well. The independant gorilla in the Medicare and Medicaid space in the US. Did have a little bit of a pullback and consolidation. A very positive story and good momentum based on last quarter earnings.

PAST TOP PICK
PAST TOP PICK
March 21, 2018

(A Top Pick May 10/17, Up 30%) Pure health insurance in the U.S. and expects it be the dominant player. Made a tremendous acquisition 2012 that's paid off. Stock is a great performer, and he likes the sector, too, which will consolidate.

Show full opinionHide full opinion

(A Top Pick May 10/17, Up 30%) Pure health insurance in the U.S. and expects it be the dominant player. Made a tremendous acquisition 2012 that's paid off. Stock is a great performer, and he likes the sector, too, which will consolidate.

COMMENT
COMMENT
January 30, 2018

Amazon, Berkshire Hathaway and J.P. Morgan just announced forming a healthcare company aimed at cutting costs. The experiment with government led healthcare mandates really didn’t work. There was far too much friction between opposing views. If you own the stock, you shouldn't get too excited about just one day, or the fact that insurers are going to go away.

Show full opinionHide full opinion

Amazon, Berkshire Hathaway and J.P. Morgan just announced forming a healthcare company aimed at cutting costs. The experiment with government led healthcare mandates really didn’t work. There was far too much friction between opposing views. If you own the stock, you shouldn't get too excited about just one day, or the fact that insurers are going to go away.

PAST TOP PICK
PAST TOP PICK
December 7, 2017

(A Top Pick Jun 13/17, Up 23%) They have a couple of headwinds right now. There is a health insurer thing rolling off that is a one year thing. He continues to like them.

Show full opinionHide full opinion

(A Top Pick Jun 13/17, Up 23%) They have a couple of headwinds right now. There is a health insurer thing rolling off that is a one year thing. He continues to like them.

PAST TOP PICK
PAST TOP PICK
November 7, 2017

(A Top Pick June 13/17. Up 18%.) This has been an absolute hero. It has several tailwinds. It is the dominant Medicare/Medicaid provider. Management is intent on returning 50% of free cash flow. It has all the right factors. He still likes this.

Show full opinionHide full opinion

(A Top Pick June 13/17. Up 18%.) This has been an absolute hero. It has several tailwinds. It is the dominant Medicare/Medicaid provider. Management is intent on returning 50% of free cash flow. It has all the right factors. He still likes this.

Showing 31 to 45 of 109 entries